Abnormal brain protein synthesis in language areas of children with pervasive developmental disorder: A L-[1-11C]-leucine PET study

Journal of Child Neurology

Volumn 26, Issue 11, 2011, Pages 1347-1354

  Shandal, Varun ^a,b   Sundaram, Senthil K ^a,b   Chugani, Diane C ^a,b   Kumar, Ajay ^a,b   Behen, Michael E ^a,b   Chugani, Harry T ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

autism; cerebral protein synthesis; developmental delay; pervasive developmental disorder; positron emission tomography

Indexed keywords

BRAIN PROTEIN; LEUCINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFERIOR FRONTAL GYRUS; INFERIOR PARIETAL LOBULE; LANGUAGE DEVELOPMENT; MALE; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RATING SCALE; SCHOOL CHILD;

ANALYSIS OF VARIANCE; BRAIN MAPPING; CARBON ISOTOPES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; LEUCINE; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BIOSYNTHESIS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 80455167907     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811405200     Document Type: Article

References (40)

1. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003 ; 60: 367-380 (Pubitemid 36188229)
2. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr. 2000 ; 136: 593-598 (Pubitemid 30318387)
3. Auerbach BD, Bear MF. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis. J Neurophysiol. 2010 ; 104: 1047-1051
4. Wang H, Kim SS, Zhuo M. Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization. J Biol Chem. 2010 ; 285: 21888-21901
5. Napolioni V, Moavero R, Curatolo P. Recent advances in neurobiology of tuberous sclerosis complex. Brain Dev. 2009 ; 31: 104-113
6. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet. 1991 ; 41: 289-294
7. Purpura DP. Dendritic spine "dysgenesis" and mental retardation. Science. 1974 ; 186: 1126-1128
8. Grossman AW, Aldridge GM, Weiler IJ, Greenough WT. Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond. J Neurosci. 2006 ; 26: 7151-7155
9. Sin WC, Haas K, Ruthazer ES, Cline HT. Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases. Nature. 2002 ; 419: 475-480
10. Tashiro A, Yuste R. Regulation of dendritic spine motility and stability by Rac1 and Rho kinase: evidence for two forms of spine motility. Mol Cell Neurosci. 2004 ; 26: 429-440 (Pubitemid 38968436)
11. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010 ; 466: 368-372
12. Kleim JA, Bruneau R, Calder K, et al. Functional organization of adult motor cortex is dependent upon continued protein synthesis. Neuron. 2003 ; 40: 167-176 (Pubitemid 37222471)
13. Sundaram SK, Sivaswamy L, Makki MI, Behen ME, Chugani HT. Absence of arcuate fasciculus in children with global developmental delay of unknown etiology: a diffusion tensor imaging study. J Pediatr. 2008 ; 152: 250-255
14. Smith CB, Schmidt KC, Qin M, et al. Measurement of regional rates of cerebral protein synthesis with L-[1-11C]-leucine and PET with correction for recycling of tissue amino acids: II. Validation in rhesus monkeys. J Cereb Blood Flow Metab. 2005 ; 25: 629-640 (Pubitemid 40562935)
15. Sundaram SK, Muzik O, Chugani DC, Mu F, Mangner TJ, Chugani HT. Quantification of protein synthesis in the human brain using L-[1-11C]-leucine PET: incorporation of factors for large neutral amino acids in plasma and for amino acids recycled from tissue. J Nucl Med. 2006 ; 47: 1787-1795 (Pubitemid 47545000)
16. Schmidt KC, Cook MP, Qin M, Kang J, Burlin TV, Smith CB. Measurement of regional rates of cerebral protein synthesis with L-[1-11C]-leucine and PET with correction for recycling of tissue amino acids: I. Kinetic modeling approach. J Cereb Blood Flow Metab. 2005 ; 25: 617-628 (Pubitemid 40562934)
17. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, et al. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med. 1995 ; 36: 1249-1254
18. Gjedde A. High- and low-affinity transport of D-glucose from blood to brain. J Neurochem. 1981 ; 36: 1463-1471 (Pubitemid 11070813)
19. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983 ; 3: 1-7 (Pubitemid 13129630)
20. Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl Med Biol. 2003 ; 30: 833-844 (Pubitemid 38040992)
21. Keen RE, Barrio JR, Huang SC, Hawkins RA, Phelps ME. In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetic models for positron emission tomography. J Cereb Blood Flow Metab. 1989 ; 9: 429-445 (Pubitemid 19183290)
22. Hawkins RA, Huang SC, Barrio JR, et al. Estimation of local cerebral protein synthesis rates with L-[1-11C]-leucine and PET: methods, model, and results in animals and humans. J Cereb Blood Flow Metab. 1989 ; 9: 446-460 (Pubitemid 19183291)
23. Mu F, Mangner TJ, Chugani HT. Facile Synthesis of L-[1-C-11]-leucine as a PET radiotracer for the measurement of cerebral protein synthesis. J Labelled Comp Radiopharm. 2005 ; 48: S189 - S189
24. Bishu S, Schmidt KC, Burlin T, et al. Regional rates of cerebral protein synthesis measured with L-[1-11C]-leucine and PET in conscious, young adult men: normal values, variability, and reproducibility. J Cereb Blood Flow Metab. 2008 ; 28: 1502-1513
25. Alkonyi B, Chugani HT, Muzik O, et al. Increased L-[1-(11) C]-leucine uptake in the leptomeningeal angioma of Sturge-Weber syndrome: a PET study. J Neuroimaging. 2011 ;:
26. Sun Y, Deibler GE, Jehle J, et al. Rates of local cerebral protein synthesis in the rat during normal postnatal development. Am J Physiol. 1995 ; 268: R549-561
27. Sutton MA, Schuman EM. Dendritic protein synthesis, synaptic plasticity, and memory. Cell. 2006 ; 127: 49-58 (Pubitemid 44466643)
28. Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 2010 ; 1309: 83-94
29. Irwin SA, Patel B, Idupulapati M, et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet. 2001 ; 98: 161-167 (Pubitemid 32051804)
30. Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet A. 2008 ; 146A: 2023-2037
31. Wang LW, Berry-Kravis E, Hagerman RJ. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics. 2010 ; 7: 264-274
32. Qin M, Kang J, Burlin TV, Jiang C, Smith CB. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J Neurosci. 2005 ; 25: 5087-5095 (Pubitemid 40712853)
33. Butler MG, Dasouki MJ, Zhou XP, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005 ; 42: 318-321 (Pubitemid 40523954)
34. Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet. 2009 ; 46: 1-8
35. Gervais H, Belin P, Boddaert N, et al. Abnormal cortical voice processing in autism. Nat Neurosci. 2004 ; 7: 801-802 (Pubitemid 38989501)
36. Just MA, Cherkassky VL, Keller TA, Minshew NJ. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain. 2004 ; 127: 1811-1821 (Pubitemid 39061557)
37. Muller RA, Behen ME, Rothermel RD, et al. Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study. J Autism Dev Disord. 1999 ; 29: 19-31 (Pubitemid 29118069)
38. Herbert MR, Harris GJ, Adrien KT, et al. Abnormal asymmetry in language association cortex in autism. Ann Neurol. 2002 ; 52: 588-596 (Pubitemid 35246862)
39. Boddaert N, Belin P, Chabane N, et al. Perception of complex sounds: abnormal pattern of cortical activation in autism. Am J Psychiatry. 2003 ; 160: 2057-2060 (Pubitemid 39619648)
40. Stroganova TA, Nygren G, Tsetlin MM, et al. Abnormal EEG lateralization in boys with autism. Clin Neurophysiol. 2007 ; 118: 1842-1854 (Pubitemid 47031704)